Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Kura Oncology
Biotech
Kyowa Kirin fronts $330M to share rights to Kura's leukemia drug
Kyowa is pledging up to $1.1 billion in milestones to split the U.S. profits of Kura's oral leukemia treatment as well as to secure global rights.
James Waldron
Nov 21, 2024 9:35am
Kura's leukemia drug works best when tacked onto existing combo
Jan 30, 2024 11:15am
Kura pulls up to $150M from Bristol Myers, VC Hercules loan
Nov 3, 2022 11:20am
Kura exits FDA clinical hold after agreeing to mitigation plans
Jan 21, 2022 7:20am
FDA stops Kura's early-phase leukemia trial after patient dies
Nov 24, 2021 9:55am
FDA’s renewed focus on oncology dosing spooks investors
Jun 28, 2021 11:58am
